What changes at 10mg is research capacity: the ability to run full concentration gradients, parallel experimental arms, and extended single-batch studies without the batch-change variability that limits multi-vial 5mg programmes
Innovation is exciting, but safe and evidence-based medication use should always come first
Timeline: Zepbound will be added back to commercial insurance formularies as a preferred option on Oct
Their parents hope they wont be on the drug for more than a few years
Eventually, they will see a gastroenterologist who diagnoses them with irritable bowel syndrome
The study also indicated that GLP-1 RA treatment was associated with a moderately increased risk of gallstones (RR: 1.27, 95% CI 1.101.47), cholecystitis (RR: 1.36, 95% CI 1.141.62), and overall gallbladder disease risk (RR: 1.55, 95% CI 1.082.22) compared to placebo